By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sagentia said today that it has been picked by PathoGenetix to develop a commercial scale system for rapid microbial detection and strain typing based on the Woburn, Mass.-based firm's Genome Sequence Scanning technology.

PathoGenetix plans to launch the system's first commercial application, for the research market, in late 2012.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.